Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$5.37K Sell
229
-197
-46% -$5.71K ﹤0.01% 1924
2024
Q4
$11.9K Buy
426
+207
+95% +$5.55K ﹤0.01% 1566
2024
Q3
$4.46K Buy
219
+98
+81% +$2.19K ﹤0.01% 2056
2024
Q2
$3.57K Buy
121
+15
+14% +$431 ﹤0.01% 2143
2024
Q1
$3.23K Buy
+106
New +$2.99K ﹤0.01% 2073
2023
Q4
Sell
-202
Closed -$5.98K 2710
2023
Q3
$5.98K Hold
202
﹤0.01% 1685
2023
Q2
$7.13K Buy
202
+130
+181% +$3.64K ﹤0.01% 1643
2023
Q1
$1.73K Sell
72
-7
-9% -$162 ﹤0.01% 2300
2022
Q4
$1.76K Buy
+79
New +$1.83K ﹤0.01% 2282

Other funds holding CFLT

Lindbrook Capital's CFLT Position: Q1 2025 in Review

Lindbrook Capital reduced its Confluent (CFLT) stake by 46% in Q1 2025, selling an estimated $5.71K and leaving 229 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Lindbrook Capital first reported a position in CFLT in Q4 2022 and has held it in 9 quarters since. The position peaked at $11.9K in Q4 2024. 400 funds tracked by Wall St. Rank hold CFLT as of Q1 2025.

  • Lindbrook Capital held 229 shares of Confluent worth $5.37K as of Q1 2025.
  • Lindbrook Capital sold 197 Confluent shares in Q1 2025, an estimated $5.71K.
  • Confluent made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1924 holding.
  • Lindbrook Capital first reported a position in Confluent in Q4 2022 and has held it in 9 quarters since.
  • Lindbrook Capital's Confluent position peaked at $11.9K in Q4 2024.
  • 400 funds tracked by Wall St. Rank held Confluent as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.